Global Fiducial Markers Market Size by Product, Modality, Application, End User and Region – Segment-Level Market Assessment, Growth Opportunity Analysis, Competitive Mapping & Forecast to 2034
Overview
Fiducial Markers Market size was valued at US$ 132.25 Mn in 2025 and the total revenue is expected to grow at 4.2 % through 2026 to 2034, reaching nearly US$ 191.51 Mn in the forecast period.
Fiducial Markers Market Overview:
A fiducial marker is defined as an object placed in the viewing field of an imaging system and is shown in the produced image, which is used to measure the image of the object. Fiducial markers are used in the healthcare system for defining or targeting the lesions that are to be implanted or located in soft tissues of the chest, neck, head, or pelvis.
Fiducial Markers Market Growth and Share Analysis
To know about the Research Methodology :- Request Free Sample Report
Fiducial Markers Market Dynamics:
The rising cancer population around the globe is probable to increase the market of fiducial markers in the forecast period. As per the research carried out by GLOBOCAN, around 18.6 million new cases have been reported in 2019. The major forms of cancer reported were lungs, breast, colorectal prostate, and stomach.
In addition, increases adoption of radiotherapies in cancer treatment to reduce the proliferation of cancer is likely to lift the market for fiducial markers market in the forecast period. Technological investments by a biotechnology company to increase the demand for minimally invasive surgeries are estimated to support the growth of ultrasound modalities. And this factor is expected to fuel the growth of fiducial markers in the forecast period.
In addition, growing awareness of target therapy and target medicines is projected to motivate the advance of the market. Further, radiotherapy techniques like image-guided radiotherapy, stereotactic radiosurgery, intensity-modulated radiotherapy, are the techniques likely to enhance the adoption of fiducial markers in the forecast period. moreover, the adverse effect of radiotherapy like hair fall, low immunity response, loss of appetite are the factors may slow the growth of radiotherapy.
However, complications related to product implant and usage may hamper the adoption of the fiducial marketer. As per NCBI, patients with transrectal fiducial marker insertion in the treatment of prostate cancer are likely to suffer from side effects like hematuria, dysuria, haematospermia rectal bleeding. Hence, these factors are likely to hinder the growth of the market.
Global Fiducial Markers Market Segment Analysis:
The Ultrasound Modality segment is anticipated to grow significantly in the market.
Rising preference to non-invasive or minimal painful procedures like CT/CBCT, ultrasound, X-ray, and MRI. CT/CBCT. Are prospective to amplify the growth of the market. Ultrasound modality is expected to gain a larger market share in the forecast period due to lower radiation toxicity, as compared to other imaging modalities. Further, the ability to offer real-time volumetric information together with organ tracking is likely to stimulate market growth.
As new technologies have boosted the innovation in huge machinery like CT scan machines have been developed with the addition of more slides in scanning. For instance, initially, CT-scan machinery had 26 slides and now it has been developed with the addition of slides that is in total 96 slider machines to offer more precise results and accurate identification of the infected area for the treatment. Henceforth these technologies are motivating the market growth in favorable conditions. Moreover, the COVID19 pandemic boosted the application of
The Prostate cancer segment is anticipated to adhere to the growth of the Fiducial Markers Market.
Prostate cancer is likely to stimulate the growth of the market in the forecast period due to growing product adoption for the treatment. Further, lung cancer is possible to grow at a high pace due to the high consumption of smoking and drinking. Further, technological advancement in lung cancer treatment is probable to fuel the growth of the market in the forecast period.
Further, development and innovation in products are expected to hit the growth as well as acceptance in the market. For instance, Beacon FNF by Medtronic Plc. A pre-loaded gold fiducial marker has been reported to lower the risk of complications like larger extend, and pneumothorax. Hence, these innovations are likely to wider the acceptance in the market.
The Hospital segment is supplementing the growth of the Fiducial Markers Market.
The hospital sub-segment is dominating the end-used segment of the fiducial marker. The hospital subsegment holds the largest market share of 42.1% in the forecast period. Due to technological advancement healthcare industries are adopting medical machinery like radiotherapy machines to offer improved healthcare service to the patient. A huge development is being generated in the medical machinery to offer accuracy and precise results. For instance, recent development in radiotherapy like decreased complications expanded the implication of radiotherapy. Moreover, 3-dimensional conformal radiation therapy, intensity-modulated radiation therapy, brachytherapy, radioimmune therapy are likely to boost the growth of hospitals due to their acceptance and installation by the hospital authority.
Radiotherapy centers are estimated to gain the largest market share in the forecast period due to the occurrence of cancer disease globally. And is expected to grow with the highest CAGR in the forecast period.
Fiducial Markers Market Regional Insights:
North America is leading in the Fiducial Markers market owing to the largest market share of 29.58% in 2025. North America is likely to grow by a CAGR of 4.8% in the forecast period. The growth of the region is driven by the mergers and strategic associations among the market players present in the North American Market. Further, the presence of market players like CIVCO Radiotherapy (US), IZI Medical Products (US), Boston Scientific Corporation (US), Naslund Medical AB (Sweden) are likely to boost the growth of the market. Additionally, government rules and regulations in terms of radiotherapy and the implementation of healthcare programs to generate awareness among individuals are likely to fuel the growth of the market.
Europe is marked as the fastest-growing region in the Fiducial Markers market. The growth of the market is attributed to swelling healthcare outflow and private organizations for outsourcing services are likely to motivate the growth of the market. Moreover, Europe has been marked with a diagnosis of around 3.2 million people with cancer. Moreover, breast cancer and colorectal cancer are most predominant in the region due to the rising elderly population. Hence this factor is likely to boost the growth of the market.
The objective of the report is to present a comprehensive analysis of the Global Fiducial Markers Market to the stakeholders in the industry. The past and current status of the industry with the forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that include market leaders, followers, and new entrants.
PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding the Global Fiducial Markers Market dynamics, structure by analyzing the market segments and project the Global Fiducial Markers Market size. Clear representation of competitive analysis of key players by Grade, price, financial position, Grade portfolio, growth strategies, and regional presence in the Global Fiducial Markers Market make the report investor’s guide.
Fiducial Markers Market Recent Industry Development
| Date | Company | Development | Impact |
|---|---|---|---|
| 15 January 2025 | IBA (Ion Beam Applications) | IBA launched its next-generation Visicoil linear gold fiducial markers designed for enhanced visibility in ultra-precise stereotactic body radiation therapy (SBRT). | This advancement improves target positioning accuracy during dynamic image-guided radiation procedures while significantly reducing tissue artifact interference. |
| 22 May 2025 | Civco Medical Solutions | Civco Medical Solutions secured 510(k) clearance for its new line of biocompatible polymer fiducial markers tailored for lung and prostate tumor tracking. | The approval broadens access to non-metallic placement options, minimizing CT and MRI streak artifacts during treatment planning. |
| 11 September 2025 | Best Medical International | Best Medical International completed the acquisition of specialized radiopaque marker IP assets to expand its portfolio in implantable gold and radio-opaque markers. | The move scales up global manufacturing capacity and strengthens the company’s supply line for radiation oncology departments worldwide. |
| 18 November 2025 | Carbon Medical Technologies | Carbon Medical Technologies formed a strategic collaboration with a leading radiotherapy equipment developer to integrate its BioMarc carbon markers with automated image-guidance software. | This partnership improves real-time clinical workflow integration, reducing total patient setup times in SBRT interventions. |
| 10 February 2026 | Standard Imaging | Standard Imaging introduced an updated QA phantom platform featuring integrated fiducial marker tracking for daily LINAC alignment validation. | The system speeds up routine quality assurance procedures and boosts sub-millimeter precision verification for complex radiosurgery deliveries. |
Fiducial Markers Market Scope: Inquire before buying
| Fiducial Markers Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2025 | Forecast Period: | 2026-2034 |
| Historical Data: | 2020 to 2025 | Market Size in 2025: | US $ 132.25 Mn. |
| Forecast Period 2026 to 2034 CAGR: | 4.2 % | Market Size in 2034: | US $ 191.51 Mn. |
| Segments Covered: | by Products | Gold Gold Combination Polymer Other Metal Liquid |
|
| by Modality | CT/CBCT MRI Ultrasound X-Ray |
||
| by Application | Breast Cancer Lung Cancer Prostate Cancer Head and Neck Cancer Other |
||
| by End-User | Radiotherapy Center Hospitals Academic and Research Center |
||
Fiducial Markers Market, by Region
• North America (United States, Canada and Mexico)
• Europe (UK, France, Germany, Italy, Spain, Sweden, Austria and Rest of Europe)
• Asia Pacific (China, South Korea, Japan, India, Australia, Indonesia, Malaysia, Vietnam, Taiwan, Bangladesh, Pakistan and Rest of APAC)
• Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
• South America (Brazil, Argentina Rest of South America)
Fiducial Markers Market Key Players :
1. Stratapharma AG
2. CIVCO Medical Solutions
3. IZI Medical Products
4. Nanovi A/S
5. Boston Scientific Corporation
6. Naslund Medical AB
7. Medtronic
8. QlRad Inc.
9. JJ-Medtech
10. QFIX
11. Eckert & Ziegler
12. IBA Dosimetry GmbH.
Frequently Asked Questions:
1. What is the Global Fiducial Markers Market Value in 2025?
Ans: Global Fiducial Markers Market Value in 2025 was estimated as 132.25 million USD.
2. What is the Global Fiducial Markers market growth?
Ans: The global fiducial markers market is expected to grow at a compound annual growth rate of 4.2% from 2026 to 2034 to reach USD 191.51 million by 2034.
3. Which segment accounted for the largest Fiducial Markers market share?
Ans: North America dominated the Fiducial Markers market with a share of 33.58% in 2025. This is attributable to the presence of well-established healthcare infrastructure, strict regulations for infection control at healthcare facilities, and the high adoption of advanced infection prevention solutions.
4. Who are the key players in the Global Fiducial Markers market?
Ans: Some key players operating in the Fiducial Markers market include CIVCO Radiotherapy, IZI Medical Products, Naslund Medical AB, Medtronic, QlRad Inc., QFIX, Boston Scientific Corporation, Nanovi A/S, Eckert & Ziegler, and IBA Dosimetry.
5. What are the key driving factors for the growth of the Fiducial Markers market?
Ans: Key factors that are driving the Fiducial Markers market growth include the growing awareness about targeted radiotherapy techniques, such as image-guided radiotherapy, intensity-modulated radiotherapy, and stereotactic radiosurgery. These are the primary application area of fiducial markers.